Reata's Pipeline
Reata is the leader in developing
novel oral anti-inflammatory drugs targeting transcription factor
Nrf2.
Image by Wyman Meinzer
Reata is the leader in developing
novel oral anti-inflammatory drugs targeting transcription factor
Nrf2.
